Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Refractory/Relapse Neuroblastoma × Biological Products × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 CNS 1

Conditions

Carcinoma, Renal Cell 2 Triple Negative Breast Neoplasms 1 Refractory/Relapse Neuroblastoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, B-Cell 1 Kidney Neoplasms 1 Hodgkin Disease 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Biological Products 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05608148 2025-11-18

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Kyushu University

Phase 1 Recruiting

CNSOther solid neoplasm

Refractory/Relapse Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡